Promotion of Medical R&D in Japan under Abenomics
Yuko Ito () and
Hiroshi Nagano ()
Additional contact information
Yuko Ito: National Graduate Institute for Policy Studies, and Japan Science and Technology Agency
Hiroshi Nagano: National Graduate Institute for Policy Studies, and Keio University
No 16-11, GRIPS Discussion Papers from National Graduate Institute for Policy Studies
Abstract:
Japan fs cabinet has been pushing forward with economic policy knowns as Abenomics since December 26 in 2012. Abenomics also includes the promotion of R&D in the medical field and related legislative reforms. The Headquarters for Healthcare and Medical Strategy Promotion was established in the cabinet in 2013. In 2014, gAct to Promote Healthcare and Medical Strategy h was promulgated and included for the formulation of the Health and Medical Strategy, the creation of the Plan for Promotion of medical R&D by the Headquarters, and the newly establishment for Japan Agency for Medical Research and Development. In 2014 the Pharmaceutical Affairs Law was revised and it newly contains the strengthening of safety measures for pharmaceuticals and medical devices, the construction of regulations taking into account the characteristics of medical devices, and a new definition for regenerative medicine along with approvals for manufacturing and sales in light of its special characteristics. Further, gSakigake Package Strategy h formulated in 2014, which included an gadvanced review designation system h as a fast-track- applications. With only three years having passed since the implementation of the policies related to Abenomics in 2013, it may be premature to judge their outcome, but several positive signs are appearing.
Pages: 6 pages
Date: 2016-08
New Economics Papers: this item is included in nep-hea
References: View complete reference list from CitEc
Citations:
Downloads: (external link)
https://grips.repo.nii.ac.jp/?action=repository_ac ... bute_id=20&file_no=1
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:ngi:dpaper:16-11
Access Statistics for this paper
More papers in GRIPS Discussion Papers from National Graduate Institute for Policy Studies Contact information at EDIRC.
Bibliographic data for series maintained by ( this e-mail address is bad, please contact ).